Radiopharm Theranostics Limited Stock: price and insider trades · Australia
1 insider bought shares over the last 90 days, the latest by Riccardo Canevari, filed 01 Oct 2026.
Radiopharm Theranostics Limited: what insiders have been doing
Radiopharm Theranostics Limited is a Health Care company. Its directors and officers file their transactions with ASX. 3 insiders have disclosed 3 filings since 3 November 2025.
Both sides are active: 1 purchase and 1 sale, from 1 insider and 1 insider respectively. The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 senior executive.
The last purchase on record was published on 1 October 2026, which is 38 days ago.
With 3 filings in twelve months, the company is quieter than the median of 5 filings across the 1,619 companies we follow on the same exchange. The full history, which starts in 2026, counts 1 purchase against 1 sale.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleFinancial data
as of FY 2026FY ended June 2026 · cache
- 1,111,111 sharesShareASXISIN AU0000181851ASX:2924-03150605-2A1705098
- ShareASXISIN AU0000181851ASX:2924-03143301-2A1701137Canonical exit: 30 Dec 2026 (T+90)
- ShareASXISIN AU0000181851ASX:2924-03125075-2A1691498
3 of 3 declarations
About Radiopharm Theranostics Limited
Radiopharm Theranostics Limited is a company focused on the development of radiopharmaceutical therapies. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
